Bank Of America Corp Genocea Biosciences, Inc. Transaction History

Bank Of America Corp

  • $1.19 Trillion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022
SELL
$0.96 - $1.35 $25 - $36
-27 Reduced 0.05%
57,363 $72,000
Q4 2021

Feb 08, 2022
BUY
$0.95 - $1.99 $25 - $53
27 Added 0.05%
57,390 $67,000
Q3 2021

Nov 15, 2021
BUY
$1.74 - $2.33 $307 - $412
177 Added 0.31%
57,363 $110,000
Q2 2021

Sep 13, 2021
BUY
$2.06 - $2.82 $117,803 - $161,264
57,186 New
57,186 $134,000

Others Institutions Holding GNCA

# of Institutions
1
Shares Held
10K
Call Options Held
0
Put Options Held
0
View Full List

About GENOCEA BIOSCIENCES, INC.

GNCA Quotes by TradingView
  • Ticker GNCA
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 58,783,500
  • Description
  • Genocea Biosciences, Inc., a biopharmaceutical company, discovers and develops novel cancer immunotherapies. The company uses its proprietary discovery platform, ATLAS, which profiles each patient's CD4+ and CD8+ T cell immune responses to every target or antigen identified by next-generation sequencing of that patient's tumor. Its products incl...
More about GNCA
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email